Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo.
Cancers (Basel). 2022 Jun 15;14(12):2959. doi: 10.3390/cancers14122959.
Cancers (Basel). 2022.
PMID: 35740624
Free PMC article.
Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model.
Barsheshet Y, Voloshin T, Brant B, Cohen G, Koren L, Blatt R, Cahal S, Haj Khalil T, Zemer Tov E, Paz R, Klein-Goldberg A, Tempel-Brami C, Jacobovitch S, Volodin A, Kan T, Koltun B, David C, Haber A, Giladi M, Weinberg U, Palti Y.
Barsheshet Y, et al.
Int J Mol Sci. 2022 Nov 15;23(22):14073. doi: 10.3390/ijms232214073.
Int J Mol Sci. 2022.
PMID: 36430552
Free PMC article.
Item in Clipboard
Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study.
Gkika E, Grosu AL, Macarulla Mercade T, Cubillo Gracián A, Brunner TB, Schultheiß M, Pazgan-Simon M, Seufferlein T, Touchefeu Y.
Gkika E, et al.
Cancers (Basel). 2022 Mar 18;14(6):1568. doi: 10.3390/cancers14061568.
Cancers (Basel). 2022.
PMID: 35326718
Free PMC article.
Item in Clipboard
Cite
Cite